NFX — Nuformix Balance Sheet
0.000.00%
- £4.85m
- £4.75m
Annual balance sheet for Nuformix, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.67 | 0.464 | 0.203 | 0.02 | 0.098 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.139 | 0.333 | 0.116 | 0.016 | 0.039 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.82 | 0.825 | 0.337 | 0.059 | 0.136 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.001 | 0 | 0 | 0 | — |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 6.01 | 4.98 | 4.42 | 0.971 | 1.02 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.325 | 0.238 | 0.223 | 0.255 | 0.264 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.325 | 0.238 | 0.223 | 0.255 | 0.264 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 5.69 | 4.74 | 4.2 | 0.716 | 0.755 |
| Total Liabilities & Shareholders' Equity | 6.01 | 4.98 | 4.42 | 0.971 | 1.02 |
| Total Common Shares Outstanding |